The novel BiOAID thermoformed mask shell utilizes sterilized LDPE (or a long list of other polymers) “blister” pack materials and methods used in electronics, pharmaceutical, and food packaging industries. Method easily scales to deliver greater than 100M masks monthly in the U.S. Because the filter is removable, the shell can be separately sanitized using a disinfectant or soap and water.
BiOAID’s 2” x 4” strip of commonly available HEPA or MERV13 filter with a boundary layer added at the breathing apparatus offers an alternate to conventional N95 respirators composed of melt-blown polymers. The filter is delivered in a patent-pending replaceable cartridge to further ease pressure on the supply chain and to reduce both the manufacturing cost and the retail price.
The semi-rigid face mask shape conforms to NIOSH requirements, meeting current regulatory requirements. Plans are in process that will bring the respirator into non-emergency, regular FDA compliance for long-term sustainability. Our technology is cost-competitive with conventional N95 respirator manufacturing: We’re in it for the longer haul, together with everyone!
The turned-radius design creates a rounded edge and curvature for improved seal and comfort. Conforms to varying facial contours, and easily accommodates beards and facial hair. A lack of crevices and slots enhances ease of sterilization and user safety.
BiOAID is designed for single or multiple use. Re-use is easily achieved with sterilization methods commonly used in clinical or home-based and emergency settings.
500K-plus masks will fit into standard 40-foot semi-trailers, where gamma-sterilization can occur en route to distribution centers.
Using alternate materials and form factors, the BiOAID is a novel, feasible, scalable technology available for immediate manufacture and widespread distribution and use. Note that proper use of the BiOAID, like any mask or respirator is critical, and that recommendations for use are governed by applicable health regulations and recommendations by legal and expert health authorities. Use of masks and respirators for most people will continue to be one of several risk-reduction strategies considered significant in the fight against COVID-19, such as handwashing and social distancing.
Calling thermoforming and paper pulp manufacturers to join us today in producing and distributing the BiOAID mask.
Looking to partner with plastics thermoforming and paper pulp entities capable of producing 100,000 masks/week. We can provide CAD files and tool and die to initiate, as needed.